Scotiabank initiated coverage of Teva (TEVA) with an Outperform rating and $35 price target
TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on TEVA:
- Teva sees cash flow ‘probably around’ $2.7B in 2027
- Trump Weekly: White House postpones healthcare proposal after backlash
- Trump Trade: Trump says ‘tremendous progress’ on ending Ukrainian war
- JPMorgan views Medicare price cuts as inline with expectations
- Teva receives EC approvals for PONLIMSI, DEGEVMA